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• Olfactory neuroblastoma is a rare tumour in the anterior skull base with frequent intracranial 
extension. Combined management between otolaryngologist and neurosurgeons are best to 
ensure complete tumour resection and to minimize the complications of treatment  
 
• Endoscopic resection of the nasal part of the tumour is not only for aesthetic consideration. 
The superior illumination and visualization offered by the endoscopy enables the surgeon to 
adequately resect the tumour especially in the posterior ethimoid and sphenoid sinuses.  
 
• A frontal craniotomy approach allows the surgeon to better appreciate the intracranial extent 
of tumour and to ensure an adequate dura resection margin. In addition, a craniotomy 
approach allows a water-tight dura closure with stitches and reinforcement by a vascularized 
galeal-pericranial flap, minimizing post operative cerebrospinal fluid leakage.  
 
• In our case series of 14 patients spanning 14 years, only one patient died of disease.  The ten-
year overall survival is 93%.  Seven patients have local or regional recurrence; all except one 
was salvaged with additional surgery and/or radiotherapy.  The survival results are 
comparable to open craniofacial resection.   
 
• Our results showed that intracranial extension of disease (Kadish stage C) increased the risk 
for disease recurrence. Loco-regional regional recurrence can be salvaged with addition 




Keywords: olfactory neuroblastoma; esthesioneuroblastoma; craniofacial resection; 
cranionasal resection; endoscopic skull base surgery 
  
Dear Editor, 
Olfactory neuroblastoma is a rare malignancy in the anterior skull base, 
originates in the upper nasal vault with frequent extension to intracranial structures.  
The gold standard of management has been open craniofacial resection.  A meta-
analysis by Dulguerov et al. in 2001 analyzed the 390 cases reported in the literature 
from 1990 to 2001 and found a mean 5-year overall survival of 45%1.  With the 
improvement of endoscopic instruments and maturation of the endoscopic surgical 
techniques, there are increasing reports of resection of olfactory neuroblastoma with 
an endoscopic approach, with or without craniotomy.  Our center had reported the use 
of an endoscopic-assisted approach for resection of olfactory neuroblastoma in 1997 
and 20052, 3.  We would like to report the long-term results of our cohort of patients 
with olfactory neuroblastoma managed by an endoscopic-assisted technique. 
 
Patients and methods 
 The present cohort is a retrospective review of a series of 14 consecutive 
patients with olfactory neuroblastoma treated with an endoscopic assisted plus frontal 
craniotomy approach from 1998 to 2012.  The review has been approved by the 
institute review board.  There are 10 male and 4 female patients with age ranged from 
24 to 76 (median 49).  All patients had contrast computer tomography (CT) scans and 
contrast magnetic resonance imaging (MRI) scans before the operation.  The Kadish 
staging system is used4.  
The surgical technique is similar to the technique described by Yuen et al. in 
1997 and 20052, 3.  The operation is a two-team approach by neurosurgeons working 
from the anterior cranial fossa and otolaryngologist working from the nasal cavity.  
The two teams started the operation simultaneously.  The otolaryngologist debulked 
the tumour, performed a ethimoidectomy and removed the area of the lamina 
papyracea in contact with tumour. The whole skull base and the cribriform plate 
would be exposed.  The neurosurgeon started with a bifrontal craniotomy and opened 
the frontal lobe dura to expose the frontal lobes.  Cerebrospinal fluid (CSF) was 
allowed to drain through the dura incision and the brain was allowed to fall 
posteriorly under gravity, exposing the olfactory nerves, crista galli and cribriform 
plate.  There was no need for retraction of the frontal lobe.  Depending on the extent 
of dural invasion, the anterior fossa dura was incised circumferential around the 
cribriform plate with a margin from the tumor.  Both olfactory nerves would be 
divided as they emerged from the frontal lobe and if there were any area of frontal 
lobe invasion, these would be resected enbloc with the dura and cribriform plate.  
Figure 1 shows the view of the cribriorm plate from above with the tumour in situ.   
The dura basal defect would be repaired with a free temporalis fascia and a galeal-
pericranial flap would be harvested for future repair of the skull base defect.  The 
skull base was then drilled on both sides, just medial to the lamina papyracea and 
lateral to the cribriform plate, usually from above by the neurosurgeon, with the 
otolaryngologist shining the light of the endoscope from below to guide the site for 
drilling.  The whole cribriform plate was drilled out in four sides and removed enbloc 
with both middle turbinates and the nasal septum from the cranial side.  Figure 2 
showed the photo of the resected specimen.  The dura was then repaired with a 
temporalis fascia graft and the skull base repaired with the galeal-pericranial flap.  
The nasal cavities would be packed with bismuth iodoform paraffin gauze.  No 
external ventricular drainage, lumber drain or tracheostomy was performed and the 
patients were extubated and allowed to wake up in the neurosurgical intensive care 
unit. 
 All patients were followed up regularly in our hospital by both neurosurgeons 
and otolaryngologists.  Depending on the final pathological reports, patients would be 
referred for post-operative radiotherapy.  All patients with disease involving the dura 
or beyond (Kadish C) would be referred for radiotherapy. 
 The primary end-points assessed in the present cohort are overall survival and 
recurrence free survival.  Survival curves were plotted with the Kaplan Meier plots 
and univariate analysis for survival was performed with log rank test. All statistics 
were calculated with the software Statistical Package for Social Sciences version 20.0 
(International Business Machines, Armonk, NY, USA).  A p-value <0.05 was 
considered as statistically significant. 
 
Results 
 The majority of patients (9, 64.3%) had advanced Kadish C stage disease.  
Four (28.6%) patients Kadish B and one (7.1%) had Kadish A disease.  One patient 
had iplilateral neck lymph node metastasis on presentation.  The median operating 
time is 360 minutes (210-527 minutes), with the longest operating time for the patient 
with neck dissection.  All patients had clear frozen section margins intraoperatively 
but 3 patients had positive dural margins on formal histological analysis.  The median 
hospital stay was 13 days (9-25 days).  All patients were ambulatory upon discharge. 
Seven patients received post-operative radiotherapy.  Two patients refused 
radiotherapy.   
Survival 
 One patient died of disease at 17 months after surgery, all other patients 
survived.  For all the survivors, the follow up period ranged from 25 to 188 months 
(median 110).  The estimated mean overall survival of the cohort is 176 months (95% 
CI 153-199).  The 5-year and 10-year overall survival rates are both 93%.  Seven 
patients developed recurrence, three intracranially and three in the cervical lymph 
node.  One patient had recurrence in the ipsilateral maxillary sinus.  The time to first 
recurrence ranged from 3 months to 47 months.  The 2-year recurrence free survival 
(RFS) is 71% and 5-year RFS is 49%.  Figure 3 is the Kaplan-Meier plot of the 
overall and recurrence free survival.  All patients with recurrence were further 
salvaged with surgery and/or radiotherapy.  At the time of review, one patient died of 
disease and two patients are alive with disease.  Univariate analysis showed that only 
intracranial disease (Kadish C) is marginally significant poor RFS (p=0.086, log-rank 
test).  There were no factors predicting overall survival.  Figure 4 is the Kaplan-Meier 
plot of RFS versus intracranial disease.   
Complications 
 No patients had cerebrospinal leakage.  One patient had convulsion at second 
day after operation and no patient developed late convulsion.  Intranasal 
complications were rare.  Only one patient developed a sphenoid mucocele 10 months 
after the operation and was treated with endoscopic drainage.  Our surgical technique 
removed the whole cribriform plate and both olfactory nerves, so all patients 
developed anosmia after operation. 
 
Discussion 
 The current cohort presented one of the long-term survival data on olfactory 
neuroblastoma.   The median follow up is more than ten years (110 months) and the 
majority of the patients (11, 78.5%) have been followed up for more than ten years.  
Olfactory neuroblastoma can have late recurrence up to ten years and long follow up 
is required to critically analyze the oncological efficacy of a particular management 
protocol.  Levine et al. reported the long-term results of one of the largest cohort of 
patients with olfactory neuroblastoma treated with open craniofacial resection, with 
excellent 15 years disease free survival of 82.6%5.  The other large cohort of patients 
treated with open craniofacial resection for olfactory neuroblastoma report by Lund et 
al. reported a less favorable picture of 5-year overall survival of 61% and 10-year 
overall survival of 42%6.  Our present cohort achieved 10-year overall survival of 
93%, which is comparable to the figures achieved in open craniofacial resection. 
 There have been concerns regarding the endoscopic technique of resecting 
olfactory neuroblastomas7, 8.  The main concern was the piece meal removal of 
tumour and the uncertainly in achieving a clear resection margin.  The inability of 
obtaining a clear resection margin is a genuine concern as shown in the present cohort.  
Although we had achieved clear frozen section margins for all patients in the cohort, 
three patients had positive resection margin in the anterior fossa dura on histological 
analysis of the resected specimen.  Our practice is to offer post-operative radiotherapy 
to the anterior skull base and nasal cavities for all patients with intracranial 
involvement of the tumor, though we were not able to prove statistically that post-
operative radiotherapy improved recurrence free survival.  On the other hand, the use 
of the endoscope allows better illumination and visualization of the extent of the 
tumour in the nasal cavities.  This is especially significant in dealing with the 
posterior aspect of the tumour near the sphenoid sinus, where the visualization of the 
area around the sphenoid sinus was especially poor in open craniofacial resection.  
Better visualization of the extent of the tumor allowed a more complete resection and 
in turn, translated to better tumor control.  
 The current cohort has no cerebrospinal fluid leakage.  We attributed this to 
the craniotomy approach, allowing a watertight closure if the dura reinforced with the 
vascularized galeal-pericranial flap.   
 The main deficit of the current cohort is the limited number.  Olfactory 
neuroblastoma is a rare tumour and any single centre study would suffer from the 
same limitation.  Further studies would need multicenter cohorts to pool the patients 
for analysis.   
Conclusion  
 The current cohort demonstrated that the endoscopic-assisted technique of 
cranionasal resection of olfactory neuroblastomas allow enbloc resection of the 
anterior skull base and could achieve a high long-term survival rate comparable to the 
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Figure Legends 
Figure 1. Intraoperative photo showing the view of the cribriform plate from above.  
The blue arrow points to the intracranial portion of the tumour. 
Figure 2. Clinical photo of the resected specimen.  The arrow points to the nasal 
portion of the tumour between the left middle turbinate and the nasal septum. 
Figure 3A. Kaplan Meier plot of the overall survival of the cohort.  3B. Kaplan Meier 
plot of the recurrence free survival of the cohort. 
Figure 4.  Kaplan Meier plot of the recurrence free survival between patients with no 
intracranial extension of tumour (Kadish A and B) and patients patients with 
intracranial extension (Kadish C).  Patients with intracranial extension of disease are 
marginally significant for poor recurrence free survival (p=0.086, log rank test). 
